A. Heald, Physical health in schizophrenia: a challenge for antipsychotic therapy -European Psychiatry [WWW Document, p.71700, 2010.

M. J. Acuña, J. C. Martín, M. Graciani, A. Cruces, and F. Gotor, A Comparative Study of the Sexual Function of Institutionalized Patients with Schizophrenia, J. Sex. Med, vol.7, pp.3414-3423, 2010.

J. Ahl, B. J. Kinon, and H. Liu-seifert, Sexual Dysfunction Associated with Neuroleptic-Induced Hyperprolactinemia Improves with Reduction in Prolactin Levels, Ann. N. Y. Acad. Sci, vol.1032, pp.289-290, 2004.

D. Aizenberg, I. Modai, A. Landa, I. Gil-ad, and A. Weizman, Comparison of sexual dysfunction in male schizophrenic patients maintained on treatment with classical antipsychotics versus clozapine, J. Clin. Psychiatry, vol.62, pp.541-544, 2001.

D. Aizenberg, Z. Zemishlany, P. Dorfman-etrog, and A. Weizman, Sexual dysfunction in male schizophrenic patients, J. Clin. Psychiatry, vol.56, pp.137-141, 1995.

A. Nunes and L. V. , The accuracy of the Arizona Sexual Experience Scale (ASEX) to identify sexual dysfunction in patients of the schizophrenia spectrum, pp.101-60832009000500002, 2009.

M. Atmaca, M. Kuloglu, and E. Tezcan, A new atypical antipsychotic: quetiapine-induced sexual dysfunctions, Int. J. Impot. Res, vol.17, pp.201-203, 2005.

D. S. Baldwin, Depression and sexual dysfunction, Br. Med. Bull, vol.57, pp.81-99, 2001.

P. E. Bebbington, M. Angermeyer, J. Azorin, S. Marwaha, F. Marteau et al., Sideeffects of antipsychotic medication and health-related quality of life in schizophrenia, Acta Psychiatr. Scand, vol.119, pp.22-28, 2009.

. Beck, Depression,causesandtreatment.Philadelphia:Uni-versityofPennsylvaniaPress, 1967.

M. G. Biebel, A. L. Burnett, and H. Sadeghi-nejad, Male Sexual Function and Smoking. Sex, Med. Rev, vol.4, pp.366-375, 2016.

I. Bitter, B. R. Basson, and M. R. Dossenbach, Antipsychotic treatment and sexual functioning in first-time neuroleptic-treated schizophrenic patients, Int. Clin. Psychopharmacol, vol.20, pp.19-21, 2005.

Q. Bo, F. Dong, X. Li, Z. Wang, X. Ma et al., Prolactin related symptoms during risperidone maintenance treatment: results from a prospective, multicenter study of schizophrenia, BMC Psychiatry, vol.16, 2016.

J. Bobes, M. P. García-portilla, G. Hernández, J. Rejas, M. Garcia-garcia et al., Frequency of Sexual Dysfunction and Other Reproductive Side-effects in Patients with Schizophrenia Treated with Risperidone, Olanzapine, Quetiapine, or Haloperidol: The Results of the EIRE Study, J. Sex Marital Ther, vol.29, pp.125-147, 2003.

N. Bram, R. Rafrafi, W. Abdelghaffar, M. H. Lakhal, S. Ouanes et al., Sexual dysfunctions in Tunisian patients with schizophrenia, Sexologies, vol.23, pp.65-70, 2014.

M. A. Burke, J. P. Mcevoy, and J. C. Ritchie, A pilot study of a structured interview addressing sexual function in men with schizophrenia, Biol. Psychiatry, vol.35, pp.32-35, 1994.

M. J. Byerly, E. Lescouflair, M. T. Weber, R. M. Bugno, R. Fisher et al., An open-label trial of quetiapine for antipsychotic-induced sexual dysfunction, J. Sex Marital Ther, vol.30, pp.325-332, 2004.

M. J. Byerly, P. A. Nakonezny, B. M. Bettcher, T. Carmody, R. Fisher et al., Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: An empirical evaluation of olanzapine, risperidone, and quetiapine, Schizophr. Res, vol.86, pp.244-250, 2006.

C. Chen, T. Lin, C. Wang, and H. Shuai, Improvement of serum prolactin and sexual function after switching to aripiprazole from risperidone in schizophrenia: A case series, Psychiatry Clin. Neurosci, vol.65, pp.95-97, 2011.

P. R. Chokka and J. R. Hankey, Assessment and management of sexual dysfunction in the context of depression, Ther. Adv. Psychopharmacol, vol.8, pp.13-23, 2018.

A. Ciudad, E. Alvarez, M. Bousoño, J. M. Olivares, and J. C. Gómez, Safety and tolerability of olanzapine versus risperidone: a one-year randomized study in outpatients with schizophrenia with prominent negative symptoms, 2007.

, Actas Esp. Psiquiatr, vol.35, pp.105-114

C. , The Changes in Sexual Functioning Questionnaire (CSFQ): Development, reliability, and validity, 1997.

. Questionnaire_csfq_development_reliability_and_validity,

A. H. Clayton, H. A. Croft, and L. Handiwala, Antidepressants and sexual dysfunction: mechanisms and clinical implications, Postgrad. Med, vol.126, pp.91-99, 2014.

A. M. Costa, M. S. De-lima, M. Faria, S. R. Filho, I. R. De-oliveira et al., A naturalistic, 9-month follow-up, comparing olanzapine and conventional antipsychotics on sexual function and hormonal profile for males with schizophrenia, J. Psychopharmacol. (Oxf.), vol.21, pp.165-170, 2007.

L. Covington and P. Cola, Clozapine vs. Haloperidol: Antipsychotic Effects on Sexual Function in Schizophrenia, Sex. Disabil, vol.18, pp.41-48, 2000.

T. Dembler-stamm, J. Fiebig, A. Heinz, and J. Gallinat, Sexual Dysfunction in Unmedicated Patients with Schizophrenia and in Healthy Controls, Pharmacopsychiatry, vol.51, pp.251-256, 2018.

L. R. Derogatis, The Derogatis Interview for Sexual Functioning (DISF/DISF-SR): an introductory report, J. Sex Marital Ther, vol.23, pp.291-304, 1997.

L. R. Derogatis and A. L. Burnett, The Epidemiology of Sexual Dysfunctions, J. Sex. Med, vol.5, pp.289-300, 2008.

A. Dervaux and F. E. Omari, Troubles sexuels chez les patients schizophrènes, rôle des antipsychotiques, Presse Médicale, vol.34, issue.05, pp.83966-83967, 2005.

R. A. Dickson, W. M. Glazer, and C. Violato, A computerized self-report questionnaire for assessing sexual functioning in psychotic patients: the DGSF scale, 2001.

M. Dossenbach, Y. Dyachkova, S. Pirildar, M. Anders, A. Khalil et al., Effects of atypical and typical antipsychotic treatments on sexual function in patients with schizophrenia: 12-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study, Eur. Psychiatry, vol.21, pp.251-258, 2006.

M. Dossenbach, A. Hodge, M. Anders, B. Molnár, D. Peciukaitiene et al., Prevalence of sexual dysfunction in patients with schizophrenia: international variation and underestimation, Int. J. Neuropsychopharmacol, vol.8, pp.195-201, 2005.

J. Eberhard, E. Lindström, M. Holstad, and S. Levander, Prolactin level during 5 years of risperidone treatment in patients with psychotic disorders, Acta Psychiatr. Scand, vol.115, pp.268-276, 2007.

X. Fan, D. C. Henderson, E. Chiang, L. B. Briggs, O. Freudenreich et al., Sexual functioning, psychopathology and quality of life in patients with schizophrenia, Schizophr. Res, vol.94, pp.119-127, 2007.

T. Fanta, K. Haile, D. Abebaw, D. Assefa, and G. Hibdye, Assessment of sexual dysfunction and associated factors among patients with schizophrenia in Ethiopia, BMC Psychiatry, vol.18, 2017.

G. Fond, O. Godin, F. Schürhoff, F. Berna, B. Aouizerate et al., Inflammatory DEpression Advances in Schizophrenia (IDEAS): A precision medicine approach of the national FACE-SZ cohort, J. Affect. Disord, vol.245, pp.468-474, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02094172

P. Fortier, J. Mottard, G. Trudel, and S. Even, Study of Sexuality-Related Characteristics in Young Adults With Schizophrenia Treated With Novel Neuroleptics and in a Comparison Group of Young Adults, Schizophr. Bull, vol.29, pp.559-572, 2003.

A. Fujii, N. Yasui-furukori, N. Sugawara, Y. Sato, T. Nakagami et al., Sexual dysfunction in Japanese patients with schizophrenia treated with antipsychotics, Prog. Neuropsychopharmacol. Biol. Psychiatry, vol.34, pp.288-293, 2010.

J. Fujioi, K. Iwamoto, M. Banno, T. Kikuchi, B. Aleksic et al., Effect of Adjunctive Aripiprazole on Sexual Dysfunction in Schizophrenia: A Preliminary Open-Label Study, Pharmacopsychiatry, vol.50, pp.74-78, 2017.

L. Gao, H. Guo, Z. Liang, X. Zhong, J. Zhu et al., , 2017.

, Zhonghua Nan Ke Xue Natl. J. Androl, vol.23, pp.615-619

A. M. Ghadirian, G. Chouinard, and L. Annable, Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients, J. Nerv. Ment. Dis, vol.170, pp.463-467, 1982.

O. Godin, M. Leboyer, A. Gaman, B. Aouizerate, F. Berna et al., Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: Results from the FACE-SZ cohort, Schizophr. Res, vol.168, pp.388-394, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01755227

L. Hanssens, G. L'italien, J. Loze, R. N. Marcus, M. Pans et al., The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913), BMC Psychiatry, vol.8, 2008.

E. W. Harley, .. Boardman, J. Craig, and T. , Sexual problems in schizophrenia: prevalence and characteristics. A cross sectional survey, Soc. Psychiatry Psychiatr. Epidemiol, vol.45, pp.759-766, 2010.

R. Hayes and L. Dennerstein, The Impact of Aging on Sexual Function and Sexual Dysfunction in Women: A Review of Population-Based Studies, J. Sex. Med, vol.2, pp.317-330, 2005.

A. Higgins, M. Nash, and A. M. Lynch, Antidepressant-associated sexual dysfunction: impact, effects, and treatment. Drug Healthc, Patient Saf, vol.2, pp.141-150, 2010.

C. Hocaoglu, F. H. Celik, G. Kandemir, H. Guveli, and B. Bahceci, Sexual dysfunction in outpatients with schizophrenia in Turkey: a cross-sectional study., Sexual dysfunction in outpatients with schizophrenia in Turkey: a cross-sectional study. Shanghai Arch, Psychiatry Shanghai Arch. Psychiatry, vol.26, pp.347-356, 2014.

C. Hou, Y. Zang, R. C. Rosen, M. Cai, Y. Li et al., Sexual dysfunction and its impact on quality of life in Chinese patients with schizophrenia treated in primary care, Compr. Psychiatry, vol.65, pp.116-121, 2016.

O. Howes, Sexual function and gonadal hormones in patients taking antipsychotic treatment for schizophrenia or schizoaffective disorder, J. Clin. Psychiatry, vol.68, pp.361-367, 2007.

M. Hummer, G. Kemmler, M. Kurz, I. Kurzthaler, H. Oberbauer et al., Sexual Disturbances During Clozapine and Haloperidol Treatment for Schizophrenia, Am. J. Psychiatry, vol.156, pp.631-633, 1999.

H. Jeong, M. Lee, H. Lee, Y. Ko, C. Han et al., Changes in sexual function and gonadal axis hormones after switching to aripiprazole in male schizophrenia patients: a prospective pilot study, Int. Clin. Psychopharmacol, vol.27, pp.177-183, 2012.

K. R. Kaufman, M. Coluccio, M. Linke, E. Noonan, R. Babalola et al., Alprazolaminduced dose-dependent anorgasmia: case analysis, BJPsych Open, vol.4, pp.274-277, 2018.

D. L. Kelly and R. R. Conley, A randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia, Psychoneuroendocrinology, vol.31, pp.340-346, 2006.

D. L. Kelly and R. R. Conley, Evaluating sexual function in patients with treatment-resistant schizophrenia, Schizophr. Res, vol.63, pp.195-196, 2003.

T. Kikuchi, K. Iwamoto, K. Sasada, B. Aleksic, K. Yoshida et al., Sexual dysfunction and hyperprolactinemia in Japanese schizophrenic patients taking antipsychotics, Prog. Neuropsychopharmacol. Biol. Psychiatry, vol.37, pp.26-32, 2012.

K. Kim, C. Pae, J. Chae, W. Bahk, T. Jun et al., Effects of Olanzapine on Prolactin Levels of Female Patients With Schizophrenia Treated With Risperidone, J. Clin. Psychiatry, vol.63, pp.408-413, 2002.

B. J. Kinon, J. Ahl, H. Liu-seifert, and G. A. Maguire, Improvement in hyperprolactinemia and reproductive comorbidities in patients with schizophrenia switched from conventional antipsychotics or risperidone to olanzapine, Psychoneuroendocrinology, vol.31, pp.577-588, 2006.

E. Kirino, Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics, Ann. Gen. Psychiatry, vol.16, 2017.

H. Knegtering, M. Boks, C. Blijd, S. Castelein, . Van-den et al., A Randomized Open-Label Comparison of the Impact of Olanzapine Versus Risperidone on Sexual Functioning, J. Sex Marital Ther, vol.32, pp.315-326, 2006.

H. Knegtering, H. Bous, S. Syteman, R. Bruggeman, and D. Wiersma, A RANDOMIZED OPEN-LABEL COMPARISON OF THE IMPACT OF ARIPIPRAZOLE VERSUS RISPERIDONE ON SEXUAL FUNCTIONING (RAS STUDY), Abstracts of the 1st Schizophrenia International Research Society Conference, vol.102, 2008.

R. Knegtering, S. Castelein, H. Bous, J. Van-der-linde, R. Bruggeman et al., A Randomized Open-Label Study of the Impact of Quetiapine Versus Risperidone on Sexual Functioning, J. Clin. Psychopharmacol, vol.24, pp.56-61, 2004.


G. Kockott and W. Pfeiffer, Sexual disorders in nonacute psychiatric outpatients, Compr. Psychiatry, vol.37, pp.56-61, 1996.

A. Kokoszka and A. Kwiatkowska, Prevalence of subjectively assessed symptoms of sexual disorders in schizophrenia, Arch. Psychiatry Psychother, vol.10, 2010.

B. Konarzewska, S. Wo?czy?ski, A. Szulc, B. Gali?ska, R. Pop?awska et al., Effect of risperidone and olanzapine on reproductive hormones, psychopathology and sexual functioning in male patients with schizophrenia, Psychoneuroendocrinology, vol.34, pp.129-139, 2009.

O. Kontula and E. Haavio-mannila, The Impact of Aging on Human Sexual Activity and Sexual Desire, J. Sex Res, vol.46, pp.46-56, 2009.

J. Kotin, D. E. Wilbert, D. Verburg, and S. M. Soldinger, Thioridazine and sexual dysfunction, Am. J. Psychiatry, vol.133, pp.82-85, 1976.

J. R. Kovac, C. Labbate, R. Ramasamy, D. Tang, and L. I. Lipshultz, Effects of cigarette smoking on erectile dysfunction, Andrologia, vol.47, pp.1087-1092, 2015.

M. Lambert, P. Conus, P. Eide, R. Mass, A. Karow et al., Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence, Eur. Psychiatry, vol.19, pp.415-422, 2004.

P. Langis, B. Germain, D. Normandeau, and M. Ross, La sexualité humaine, 2e édition, Ouvertures psychologiques, 2015.

E. O. Laumann, A. Paik, and R. C. Rosen, Sexual dysfunction in the United States: prevalence and predictors, JAMA, vol.281, pp.537-544, 1999.

J. Lee, S. Kim, Y. Lee, H. Kang, S. Kim et al., Factors associated with self-rated sexual function in Korean patients with schizophrenia receiving risperidone monotherapy, Hum. Psychopharmacol. Clin. Exp, vol.30, pp.416-424, 2015.

R. W. Lewis, K. S. Fugl-meyer, G. Corona, R. D. Hayes, E. O. Laumann et al., Definitions/epidemiology/risk factors for sexual dysfunction, J. Sex. Med, vol.7, pp.1598-1607, 2010.

O. Licitsyna, Sexual dysfunction and antidepressants, 2011.

H. Liu-seifert, B. J. Kinon, C. J. Tennant, J. Sniadecki, and J. Volavka, Sexual dysfunction in patients with schizophrenia treated with conventional antipsychotics or risperidone, Neuropsychiatr. Dis. Treat, vol.5, pp.47-54, 2009.

G. C. Lyketsos, P. Sakka, and A. Mailis, The sexual adjustment of chronic schizophrenics: a preliminary study, Br. J. Psychiatry, vol.143, pp.376-382, 1983.

S. Macdonald, J. Halliday, T. Macewan, V. Sharkey, S. Farrington et al., Nithsdale Schizophrenia Surveys 24: sexual dysfunction: Case-control study, Br. J. Psychiatry, vol.182, pp.50-56, 2003.

A. Mahmoud, K. P. Hayhurst, R. J. Drake, and S. W. Lewis, Sexual function of patients with schizophrenia receiving first-generation (FGA) or second-generation antipsychotic (SGA) treatment, Int. J. Psychiatry Clin. Pract, vol.16, pp.148-152, 2012.

A. Mahmoud, K. P. Hayhurst, R. J. Drake, and S. W. Lewis, Sexual function of patients with schizophrenia receiving first-generation (FGA) or second-generation antipsychotic (SGA) treatment, Int. J. Psychiatry Clin. Pract, vol.16, pp.148-152, 2012.

A. Mahmoud, K. P. Hayhurst, R. J. Drake, and S. W. Lewis, Second Generation Antipsychotics Improve Sexual Dysfunction in Schizophrenia: A Randomised Controlled Trial, 2011.

, Schizophr. Res. Treat

A. Mahmoud, K. P. Hayhurst, R. J. Drake, S. W. Lewis, and T. R. Barnes, The ANNSERS (Antipsychotic Non-Neurological Side Effects Rating Scale): Validation of Sexual Side-Effect Measurement, Ther. Adv. Psychopharmacol, vol.1, pp.97-100, 2011.

P. Malik, G. Kemmler, M. Hummer, A. Riecher-roessler, R. S. Kahn et al., Sexual dysfunction in first-episode schizophrenia patients: results from European First Episode Schizophrenia Trial, J. Clin. Psychopharmacol, vol.31, pp.274-280, 2011.

J. Mallet, Y. Le-strat, F. Schürhoff, N. Mazer, C. Portalier et al., FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group, 2017. Cigarette smoking and schizophrenia: a specific clinical and therapeutic profile? Results from the FACE-Schizophrenia cohort, Prog. Neuropsychopharmacol. Biol. Psychiatry, vol.79, pp.332-339

J. C. Martín, M. J. Acuña, J. Labrador, M. Blanco, and C. Casas, Sexual dysfunction factors in patients with schizophrenia treated with second generation antipsychotics: not only prolactin, Actas Esp. Psiquiatr, vol.46, pp.217-225, 2018.

M. P. Mccabe, I. D. Sharlip, R. Lewis, E. Atalla, R. Balon et al., Incidence and Prevalence of Sexual Dysfunction in Women and Men: A Consensus Statement from the Fourth International Consultation on Sexual Medicine, J. Sex. Med, vol.13, pp.144-152, 2015.

. Mccool, Prevalence of Female Sexual Dysfunction Among Premenopausal Women: A Systematic Review and Meta-Analysis of Observational Studies -Sexual Medicine Reviews [WWW Document, 2016.

C. A. Mcgahuey, A. J. Gelenberg, C. A. Laukes, F. A. Moreno, P. L. Delgado et al., The Arizona Sexual Experience Scale (ASEX): reliability and validity, J. Sex Marital Ther, vol.26, pp.25-40, 2000.

Y. Mehmet-ogur, Relationship between Smoking and Female Sexual Dysfunction. Androl.-Open Access 04, 2015.

A. Millier, I. Amri, L. Boyer, P. Auquier, and M. Toumi, Utility decrements associated with side effects in schizophrenia, J. Med. Econ, vol.17, pp.853-861, 2014.

A. Mir, K. Shivakumar, R. J. Williamson, V. Mcallister, V. O'keane et al., Change in sexual dysfunction with aripiprazole: a switching or add-on study, J. Psychopharmacol. Oxf. Engl, vol.22, pp.244-253, 2008.

I. Montalvo, L. Ortega, X. López, M. Solé, R. Monseny et al., Changes in prolactin levels and sexual function in young psychotic patients after switching from long-acting injectable risperidone to paliperidone palmitate, Int. Clin. Psychopharmacol, vol.28, pp.46-49, 2013.

A. L. Montejo, M. García, M. Espada, F. Rico-villademoros, G. Llorca et al., Psychometric characteristics of the psychotropic-related sexual dysfunction questionnaire. Spanish work group for the study of psychotropic, 2000.

, Actas Esp. Psiquiatr, vol.28, pp.141-150

Á. L. Montejo, S. Majadas, F. Rico-villademoros, G. Llorca, J. D. Gándara et al., Frequency of Sexual Dysfunction in Patients with a Psychotic Disorder Receiving Antipsychotics, J. Sex. Med, vol.7, pp.3404-3413, 2010.

B. Mullen, J. S. Brar, A. H. Vagnucci, and R. Ganguli, Frequency of sexual dysfunctions in patients with schizophrenia on haloperidol, clozapine or risperidone, Schizophr. Res, vol.48, pp.155-156, 2001.

A. K. Nagaraj, N. Pai, and S. Rao, A comparative study of sexual dysfunction involving risperidone, quetiapine, and olanzapine, Indian J. Psychiatry, vol.51, 2009.

M. R. Najafi, B. Ansari, M. Zare, F. Fatehi, and A. Sonbolestan, Effects of antiepileptic drugs on sexual function and reproductive hormones of male epileptic patients, Iran. J. Neurol, vol.11, pp.37-41, 2012.

J. Nakhli, S. Bouhlel, B. Amamou, Y. El-kissi, and B. Ben-hadj-ali, P.3.f.002 Sexual dysfunction in outpatients with schizophrenia, Eur. Neuropsychopharmacol, vol.24, pp.70907-70908, 2014.

P. A. Nakonezny, M. J. Byerly, and A. J. Rush, The Relationship between Serum Prolactin Level and Sexual Functioning among Male Outpatients with Schizophrenia or Schizoaffective Disorder: A Randomized Double-Blind Trial of Risperidone vs, Quetiapine. J. Sex Marital Ther, vol.33, pp.203-216, 2007.

M. Olfson, T. Uttaro, W. H. Carson, and E. Tafesse, Male sexual dysfunction and quality of life in schizophrenia, J. Clin. Psychiatry, vol.66, pp.331-338, 2005.

K. Y. Ong, E. R. Ramli, and H. C. Ismail, Factors associated with sexual dysfunction among schizophrenia men with nicotine dependency and non-smoking schizophrenia men, Ment. Health Subst. Use, vol.7, pp.370-380, 2014.

M. Ong, E. R. Ramli, C. Ismail, and H. , Remitted Male Schizophrenia Patients with Sexual Dysfunction, J. Sex. Med, vol.11, pp.956-965, 2014.

V. Perez, F. Cañas, and M. Tafalla, A 12-month, open-label, comparative study of quetiapine and risperidone in the acute and long-term treatment of schizophrenia, Int. Clin. Psychopharmacol, vol.23, pp.138-149, 2008.

D. O. Perkins, Predictors of noncompliance in patients with schizophrenia, J. Clin. Psychiatry, vol.63, pp.1121-1128, 2002.

J. Peuskens, Risperidone in the Treatment of Patients with Chronic Schizophrenia: a Multi-National, Multi-Centre, Double-Blind, Parallel-Group Study versus Haloperidol, Br. J. Psychiatry, vol.166, pp.712-726, 1995.

W. Pfeiffer, G. Kockott, B. Fischl, and G. Schleuning, Adverse effects of long-term psychopharmacologic therapy on sexual functions, Psychiatr. Prax, vol.18, pp.92-98, 1991.

R. Porto, Dépression et sexualité, Presse Médicale, vol.43, pp.1111-1115, 2014.

S. G. Potkin, J. Loze, C. Forray, R. A. Baker, C. Sapin et al., Reduced sexual dysfunction with aripiprazole once-monthly versus paliperidone palmitate: results from QUALIFY, Int. Clin. Psychopharmacol, vol.32, pp.147-154, 2017.

G. Raghuthaman, R. Venkateswaran, and R. Krishnadas, Adjunctive aripiprazole in risperidoneinduced hyperprolactinaemia: double-blind, randomised, placebo-controlled trial, BJPsych Open, vol.1, pp.172-177, 2015.

M. A. Rettenbacher, A. Hofer, C. Ebenbichler, S. Baumgartner, M. Edlinger et al., Prolactin Levels and Sexual Adverse Effects in Patients With Schizophrenia During Antipsychotic Treatment, J. Clin. Psychopharmacol, vol.30, pp.711-715, 2010.

R. Rosen, C. Brown, J. Heiman, S. Leiblum, C. Meston et al., The Female Sexual Function Index (FSFI): a multidimensional selfreport instrument for the assessment of female sexual function, J. Sex Marital Ther, vol.26, pp.191-208, 2000.

R. C. Rosen, A. Riley, G. Wagner, I. H. Osterloh, J. Kirkpatrick et al., The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction, Urology, vol.49, pp.822-830, 1997.

E. Rubio-abadal, N. Del-cacho, G. Saenz-navarrete, B. Arranz, R. Cambra et al., How Hyperprolactinemia Affects Sexual Function in Patients Under Antipsychotic Treatment, J. Clin. Psychopharmacol, vol.36, pp.422-428, 2016.

M. Sánchez-fuentes, M. Santos-iglesias, P. Sierra, and J. C. , A systematic review of sexual satisfaction, Int. J. Clin. Health Psychol, vol.14, issue.14, pp.70038-70047, 2014.

S. Kumar, S. V. Sinha, and V. K. , Comparative study of sexual dysfunction and serum prolactin level associated with olanzapine, risperidone, and clozapine in patients with remitted schizophrenia, Indian J. Psychiatry, vol.57, pp.386-391, 2015.

D. Sechter, J. Peuskens, O. Fleurot, W. Rein, and Y. Lecrubier, Amisulpride vs. risperidone in chronic schizophrenia: results of a 6-month double-blind study, Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol, vol.27, pp.1071-1081, 2002.

A. Serretti and A. Chiesa, A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics, Int. Clin. Psychopharmacol, vol.26, pp.130-140, 2011.

M. Simiyon, P. S. Chandra, and G. Desai, Sexual dysfunction among women with Schizophrenia-A cross sectional study from India, Asian J. Psychiatry, vol.24, pp.93-98, 2016.

S. M. Smith, V. O'keane, and R. Murray, Sexual dysfunction in patients taking conventional antipsychotic medication, Br. J. Psychiatry J. Ment. Sci, vol.181, pp.49-55, 2002.

J. J. Spollen, R. G. Wooten, C. Cargile, and G. Bartztokis, Prolactin Levels and Erectile Function in Patients Treated With Risperidone, J. Clin. Psychopharmacol, vol.24, pp.161-166, 2004.

T. S. Stroup and N. Gray, Management of common adverse effects of antipsychotic medications. World Psychiatry Off, J. World Psychiatr. Assoc. WPA, vol.17, pp.341-356, 2018.

G. Sulejmanpasic-arslanagic and S. Bise, Schizophrenia and adjunctive aripiprazole for antipsychotic-induced sexual dysfunction, Eur. Neuropsychopharmacol, vol.27, pp.31599-31606, 2017.

V. Terevnikov, J. Stenberg, J. Tiihonen, M. Burkin, and G. Joffe, Add-on mirtazapine improves orgasmic functioning in patients with schizophrenia treated with first-generation antipsychotics, Nord. J. Psychiatry, vol.71, pp.77-80, 2017.

P. V. Tran, S. H. Hamilton, A. J. Kuntz, J. H. Potvin, S. W. Andersen et al., Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders, J. Clin. Psychopharmacol, vol.17, pp.407-418, 1997.

A. Ucok, C. Incesu, T. Aker, and S. Erkoc, Do psychiatrists examine sexual dysfunction in schizophrenia patients?, J. Sex. Med, vol.5, 2000.

A. Ucok, C. Incesu, T. Aker, and S. Erkoc, Sexual dysfunction in patients with schizophrenia on antipsychotic medication, Eur. Psychiatry, vol.22, pp.328-333, 2007.

Y. Wang, P. Zhang, L. Xin, L. Chen, Y. Liu et al., Chinese version of the Psychotropic-related Sexual Dysfunction Questionnaire (PRSexDQ -SALSEX): Validity and reliability for schizophrenic patients taking antipsychotics, Psychiatry Res, vol.246, pp.303-307, 2016.

J. Westheide, G. Cvetanovska, C. Albrecht, N. Bliesener, D. Cooper-mahkorn et al., Prolactin, Subjective Well-Being and Sexual Dysfunction: An Open Label Observational Study Comparing Quetiapine with Risperidone, J. Sex. Med, vol.5, pp.2816-2826, 2008.

V. S. Williams, D. S. Baldwin, S. L. Hogue, S. E. Fehnel, K. A. Hollis et al., Estimating the prevalence and impact of antidepressant-induced sexual dysfunction in 2 European countries: a cross-sectional patient survey, J. Clin. Psychiatry, vol.67, pp.204-210, 2006.

D. A. Wirshing, J. M. Pierre, S. R. Marder, C. S. Saunders, and W. C. Wirshing, Sexual side effects of novel antipsychotic medications, Schizophr. Res, vol.6, 2002.

Y. Xiang, C. Wang, T. Si, E. H. Lee, Y. He et al., The low frequency of reported sexual dysfunction in Asian patients with schizophrenia, Hum. Psychopharmacol. Clin. Exp, vol.26, pp.352-357, 2001.

N. Yasui-furukori, A. Fujii, N. Sugawara, S. Tsuchimine, M. Saito et al., No association between hormonal abnormality and sexual dysfunction in Japanese schizophrenia patients treated with antipsychotics, Hum. Psychopharmacol, vol.27, pp.82-89, 2012.

B. Yusufi, S. Mukherjee, R. Flanagan, C. Paton, G. Dunn et al., Prevalence and nature of side effects during clozapine maintenance treatment and the relationship with clozapine dose and plasma concentration, Int. Clin. Psychopharmacol, vol.22, pp.238-243, 2007.

B. Zhang, C. Wang, Z. Li, and Z. Cai, Sexual dysfunction of 298 schizophrenics, Chin. Ment. Health J, vol.15, pp.190-192, 2001.